| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=0.01uM, 1-Methylcyclopropyl 4-(((5-(4-((3-(azetidin-1-yl)propyl)sulfonyl)-2-oxopiperazin-1-yl)pyrazin-2-yl)oxy)methyl)piperidine-1-carboxylate, Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119) Ligands targeting GPR119 (Novartis, 57930109) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/57930109 |
| Similar Terms | |
| Downloads & Tools |
4 genes differentially expressed following the CA-06-FY97_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| CCL20 | chemokine (C-C motif) ligand 20 | 0.273021 |
| RPL37A | ribosomal protein L37a | 0.260453 |
| SRMS | src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites | 0.216029 |
| FAU | Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed | 0.216029 |